Glucose Intolerance after a Recent History of Gestational Diabetes Based on the 2013 WHO Criteria

Uncertainty exists on the prevalence of glucose intolerance in women with a recent diagnosis of gestational diabetes (GDM) based on a two-step screening strategy and the 2013 World Health Organization (WHO) criteria. Our aim was to evaluate the uptake of postpartum screening, the prevalence and the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2016-06, Vol.11 (6), p.e0157272-e0157272
Hauptverfasser: Benhalima, Katrien, Jegers, Katleen, Devlieger, Roland, Verhaeghe, Johan, Mathieu, Chantal
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0157272
container_issue 6
container_start_page e0157272
container_title PloS one
container_volume 11
creator Benhalima, Katrien
Jegers, Katleen
Devlieger, Roland
Verhaeghe, Johan
Mathieu, Chantal
description Uncertainty exists on the prevalence of glucose intolerance in women with a recent diagnosis of gestational diabetes (GDM) based on a two-step screening strategy and the 2013 World Health Organization (WHO) criteria. Our aim was to evaluate the uptake of postpartum screening, the prevalence and the risk factors for glucose intolerance in women with a recent history of GDM. Retrospective analysis of the medical records of women with a recent history of GDM diagnosed in a universal two-step screening strategy with the 2013 WHO criteria. All women with a history of GDM are advised to undergo a 75g oral glucose tolerance test (OGTT) around 12 weeks postpartum. Indices of insulin sensitivity (the Matsuda index and the reciprocal of the homeostasis model assessment of insulin resistance, 1/HOMA-IR) and an index of beta-cell function, the Insulin Secretion-Sensitivity Index-2 (ISSI-2) were calculated based on the OGTT postpartum. Multivariable logistic regression was used to adjust for confounders such as age, BMI, ethnicity and breastfeeding. Of the 191 women with GDM, 29.3% (56) did not attend the scheduled postpartum OGTT. These women had a higher BMI (28.6 ±6.8 vs. 26.2 ± 5.6, p = 0.015), were more often from an ethnic minority (EM) background (41.1% vs. 25.2%, p = 0.029) and smoked more often during pregnancy (14.3% vs. 2.2%, p = 0.001) than women who attended the OGTT postpartum. Of all women (135) who received an OGTT postpartum, 42.2% (57) had prediabetes (11.9% impaired fasting glucose, 24.4% impaired glucose tolerance and 5.9% both impaired fasting and impaired glucose tolerance) and 1.5% (2) had overt diabetes. Compared to women with a normal OGTT postpartum, women with glucose intolerance were older (32.5±4.3 vs. 30.8±4.8 years, p = 0.049), were more often obese (34.5% vs. 17.3%, p = 0.023), were more often from an EM background (33.9% vs. 18.4%, p = 0.040), less often breastfed (69.5% vs. 84.2%, p = 0.041) and had more often an abnormal fasting glycaemia at the time of the OGTT in pregnancy (55.6% vs. 37.3%, p = 0.040). In the multivariable logistic regression, an EM background [OR = 2.76 (1.15-6.62), p = 0.023] and the HbA1c level at the time of the OGTT in pregnancy [OR = 4.78 (1.19-19.20), p = 0.028] remained significant predictors for glucose intolerance postpartum. Women with glucose intolerance postpartum had a similar insulin sensitivity [Matsuda index 0.656 (0.386-1.224) vs. 0.778 (0.532-1.067), p = 0.709; 1/HOMA-IR 0.004 (0.002-0.009) vs. (0
doi_str_mv 10.1371/journal.pone.0157272
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1795664559</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A454759947</galeid><doaj_id>oai_doaj_org_article_6729349b92d44a41ab4277a76ad0b2dc</doaj_id><sourcerecordid>A454759947</sourcerecordid><originalsourceid>FETCH-LOGICAL-c791t-c185f18ef9da540f2b4e06874948f156624a92da6c6e1d9ec220011552b604c83</originalsourceid><addsrcrecordid>eNqNk11rFDEUhgdRrFb_gWhAEL3YNcnkY3Ij1KrtQqFQvy7DmcyZ3ZTZSU0yYv-9WbstXSkoczFD5nnfc_Imp6qeMTpntWZvz8MURxjmF2HEOWVSc83vVY-YqflMcVrfv_W9Vz1O6ZxSWTdKPaz2CtpIRsWjCo6GyYWEZDHmMGCE0SGBPmMkQM7Q4ZjJsU85xEsSenKEKUP2oRQmHzy0mDGR95CwI2EkeYWEU1aT78en5DD64uLhSfWghyHh0-17v_r66eOXw-PZyenR4vDgZOa0YXnmWCN71mBvOpCC9rwVSFWjhRFNz6RSXIDhHSinkHUGHeeUMiYlbxUVrqn3qxdXvhdDSHabTrJMmyIWUppCLK6ILsC5vYh-DfHSBvD2z0KISwsxezegVZqbWpi2VBQCBINWcK1BK-hoyztXvN5tq03tGrtNThGGHdPdP6Nf2WX4aYWhvKaiGLzeGsTwYyqx2rVPDocBRgxT6buhTWlCNfzfqDZKNVIbXdCXf6F3B7GlllD26sc-lBbdxtQeCCm0NEZsvOZ3UOXpcO1duXW9L-s7gjc7gsJk_JWXMKVkF5_P_p89_bbLvrrFrhCGvEphmDb3MO2C4gp0MaQUsb85D0btZmiu07CbobHboSmy57fP8kZ0PSX1b2UGDmw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1795664559</pqid></control><display><type>article</type><title>Glucose Intolerance after a Recent History of Gestational Diabetes Based on the 2013 WHO Criteria</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Benhalima, Katrien ; Jegers, Katleen ; Devlieger, Roland ; Verhaeghe, Johan ; Mathieu, Chantal</creator><contributor>Pietropaolo, Massimo</contributor><creatorcontrib>Benhalima, Katrien ; Jegers, Katleen ; Devlieger, Roland ; Verhaeghe, Johan ; Mathieu, Chantal ; Pietropaolo, Massimo</creatorcontrib><description>Uncertainty exists on the prevalence of glucose intolerance in women with a recent diagnosis of gestational diabetes (GDM) based on a two-step screening strategy and the 2013 World Health Organization (WHO) criteria. Our aim was to evaluate the uptake of postpartum screening, the prevalence and the risk factors for glucose intolerance in women with a recent history of GDM. Retrospective analysis of the medical records of women with a recent history of GDM diagnosed in a universal two-step screening strategy with the 2013 WHO criteria. All women with a history of GDM are advised to undergo a 75g oral glucose tolerance test (OGTT) around 12 weeks postpartum. Indices of insulin sensitivity (the Matsuda index and the reciprocal of the homeostasis model assessment of insulin resistance, 1/HOMA-IR) and an index of beta-cell function, the Insulin Secretion-Sensitivity Index-2 (ISSI-2) were calculated based on the OGTT postpartum. Multivariable logistic regression was used to adjust for confounders such as age, BMI, ethnicity and breastfeeding. Of the 191 women with GDM, 29.3% (56) did not attend the scheduled postpartum OGTT. These women had a higher BMI (28.6 ±6.8 vs. 26.2 ± 5.6, p = 0.015), were more often from an ethnic minority (EM) background (41.1% vs. 25.2%, p = 0.029) and smoked more often during pregnancy (14.3% vs. 2.2%, p = 0.001) than women who attended the OGTT postpartum. Of all women (135) who received an OGTT postpartum, 42.2% (57) had prediabetes (11.9% impaired fasting glucose, 24.4% impaired glucose tolerance and 5.9% both impaired fasting and impaired glucose tolerance) and 1.5% (2) had overt diabetes. Compared to women with a normal OGTT postpartum, women with glucose intolerance were older (32.5±4.3 vs. 30.8±4.8 years, p = 0.049), were more often obese (34.5% vs. 17.3%, p = 0.023), were more often from an EM background (33.9% vs. 18.4%, p = 0.040), less often breastfed (69.5% vs. 84.2%, p = 0.041) and had more often an abnormal fasting glycaemia at the time of the OGTT in pregnancy (55.6% vs. 37.3%, p = 0.040). In the multivariable logistic regression, an EM background [OR = 2.76 (1.15-6.62), p = 0.023] and the HbA1c level at the time of the OGTT in pregnancy [OR = 4.78 (1.19-19.20), p = 0.028] remained significant predictors for glucose intolerance postpartum. Women with glucose intolerance postpartum had a similar insulin sensitivity [Matsuda index 0.656 (0.386-1.224) vs. 0.778 (0.532-1.067), p = 0.709; 1/HOMA-IR 0.004 (0.002-0.009) vs. (0.004-0.003-0.007), p = 0.384] but a lower beta-cell function compared to women with a normal OGTT postpartum, remaining significant after adjustment for confounders [ISSI-2 1.6 (1.2-2.1) vs. 1.9 (1.7-2.4),p = 0.002]. Glucose intolerance is very frequent in early postpartum in women with GDM based on the 2013 WHO criteria in a two-step screening strategy and these women have an impaired beta-cell function. Nearly one third of women did not attend the scheduled OGTT postpartum and these women have an adverse risk profile. More efforts are needed to engage and stimulate women with GDM to attend the postpartum OGTT.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0157272</identifier><identifier>PMID: 27285104</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adult ; Analysis ; Beta cells ; Biology and Life Sciences ; Blood glucose ; Blood Glucose - analysis ; Body mass ; Breast feeding ; Breastfeeding &amp; lactation ; Chromium ; Complications and side effects ; Criteria ; Demographic aspects ; Diabetes ; Diabetes mellitus ; Diabetes, Gestational - epidemiology ; Diagnosis ; Endocrinology ; Fasting ; Female ; Gestational diabetes ; Glucose ; Glucose intolerance ; Glucose Intolerance - blood ; Glucose Intolerance - diagnosis ; Glucose Intolerance - epidemiology ; Glucose tolerance ; Glucose Tolerance Test ; Gynecology ; Homeostasis ; Humans ; Insulin ; Insulin Resistance ; Insulin-Secreting Cells - pathology ; Intolerance ; Laboratory testing ; Medical records ; Medicine and Health Sciences ; Minority &amp; ethnic groups ; Obstetrics ; Population ; Postpartum ; Postpartum Period ; Prediabetic State - blood ; Prediabetic State - diagnosis ; Prediabetic State - epidemiology ; Pregnancy ; Primary care ; Regression analysis ; Retrospective Studies ; Risk analysis ; Risk assessment ; Risk Factors ; Screening ; Secretion ; Sensitivity ; Sensitivity analysis ; Strategy ; Womens health</subject><ispartof>PloS one, 2016-06, Vol.11 (6), p.e0157272-e0157272</ispartof><rights>COPYRIGHT 2016 Public Library of Science</rights><rights>2016 Benhalima et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2016 Benhalima et al 2016 Benhalima et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c791t-c185f18ef9da540f2b4e06874948f156624a92da6c6e1d9ec220011552b604c83</citedby><cites>FETCH-LOGICAL-c791t-c185f18ef9da540f2b4e06874948f156624a92da6c6e1d9ec220011552b604c83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902304/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902304/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23847,27903,27904,53769,53771,79346,79347</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27285104$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Pietropaolo, Massimo</contributor><creatorcontrib>Benhalima, Katrien</creatorcontrib><creatorcontrib>Jegers, Katleen</creatorcontrib><creatorcontrib>Devlieger, Roland</creatorcontrib><creatorcontrib>Verhaeghe, Johan</creatorcontrib><creatorcontrib>Mathieu, Chantal</creatorcontrib><title>Glucose Intolerance after a Recent History of Gestational Diabetes Based on the 2013 WHO Criteria</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Uncertainty exists on the prevalence of glucose intolerance in women with a recent diagnosis of gestational diabetes (GDM) based on a two-step screening strategy and the 2013 World Health Organization (WHO) criteria. Our aim was to evaluate the uptake of postpartum screening, the prevalence and the risk factors for glucose intolerance in women with a recent history of GDM. Retrospective analysis of the medical records of women with a recent history of GDM diagnosed in a universal two-step screening strategy with the 2013 WHO criteria. All women with a history of GDM are advised to undergo a 75g oral glucose tolerance test (OGTT) around 12 weeks postpartum. Indices of insulin sensitivity (the Matsuda index and the reciprocal of the homeostasis model assessment of insulin resistance, 1/HOMA-IR) and an index of beta-cell function, the Insulin Secretion-Sensitivity Index-2 (ISSI-2) were calculated based on the OGTT postpartum. Multivariable logistic regression was used to adjust for confounders such as age, BMI, ethnicity and breastfeeding. Of the 191 women with GDM, 29.3% (56) did not attend the scheduled postpartum OGTT. These women had a higher BMI (28.6 ±6.8 vs. 26.2 ± 5.6, p = 0.015), were more often from an ethnic minority (EM) background (41.1% vs. 25.2%, p = 0.029) and smoked more often during pregnancy (14.3% vs. 2.2%, p = 0.001) than women who attended the OGTT postpartum. Of all women (135) who received an OGTT postpartum, 42.2% (57) had prediabetes (11.9% impaired fasting glucose, 24.4% impaired glucose tolerance and 5.9% both impaired fasting and impaired glucose tolerance) and 1.5% (2) had overt diabetes. Compared to women with a normal OGTT postpartum, women with glucose intolerance were older (32.5±4.3 vs. 30.8±4.8 years, p = 0.049), were more often obese (34.5% vs. 17.3%, p = 0.023), were more often from an EM background (33.9% vs. 18.4%, p = 0.040), less often breastfed (69.5% vs. 84.2%, p = 0.041) and had more often an abnormal fasting glycaemia at the time of the OGTT in pregnancy (55.6% vs. 37.3%, p = 0.040). In the multivariable logistic regression, an EM background [OR = 2.76 (1.15-6.62), p = 0.023] and the HbA1c level at the time of the OGTT in pregnancy [OR = 4.78 (1.19-19.20), p = 0.028] remained significant predictors for glucose intolerance postpartum. Women with glucose intolerance postpartum had a similar insulin sensitivity [Matsuda index 0.656 (0.386-1.224) vs. 0.778 (0.532-1.067), p = 0.709; 1/HOMA-IR 0.004 (0.002-0.009) vs. (0.004-0.003-0.007), p = 0.384] but a lower beta-cell function compared to women with a normal OGTT postpartum, remaining significant after adjustment for confounders [ISSI-2 1.6 (1.2-2.1) vs. 1.9 (1.7-2.4),p = 0.002]. Glucose intolerance is very frequent in early postpartum in women with GDM based on the 2013 WHO criteria in a two-step screening strategy and these women have an impaired beta-cell function. Nearly one third of women did not attend the scheduled OGTT postpartum and these women have an adverse risk profile. More efforts are needed to engage and stimulate women with GDM to attend the postpartum OGTT.</description><subject>Adult</subject><subject>Analysis</subject><subject>Beta cells</subject><subject>Biology and Life Sciences</subject><subject>Blood glucose</subject><subject>Blood Glucose - analysis</subject><subject>Body mass</subject><subject>Breast feeding</subject><subject>Breastfeeding &amp; lactation</subject><subject>Chromium</subject><subject>Complications and side effects</subject><subject>Criteria</subject><subject>Demographic aspects</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes, Gestational - epidemiology</subject><subject>Diagnosis</subject><subject>Endocrinology</subject><subject>Fasting</subject><subject>Female</subject><subject>Gestational diabetes</subject><subject>Glucose</subject><subject>Glucose intolerance</subject><subject>Glucose Intolerance - blood</subject><subject>Glucose Intolerance - diagnosis</subject><subject>Glucose Intolerance - epidemiology</subject><subject>Glucose tolerance</subject><subject>Glucose Tolerance Test</subject><subject>Gynecology</subject><subject>Homeostasis</subject><subject>Humans</subject><subject>Insulin</subject><subject>Insulin Resistance</subject><subject>Insulin-Secreting Cells - pathology</subject><subject>Intolerance</subject><subject>Laboratory testing</subject><subject>Medical records</subject><subject>Medicine and Health Sciences</subject><subject>Minority &amp; ethnic groups</subject><subject>Obstetrics</subject><subject>Population</subject><subject>Postpartum</subject><subject>Postpartum Period</subject><subject>Prediabetic State - blood</subject><subject>Prediabetic State - diagnosis</subject><subject>Prediabetic State - epidemiology</subject><subject>Pregnancy</subject><subject>Primary care</subject><subject>Regression analysis</subject><subject>Retrospective Studies</subject><subject>Risk analysis</subject><subject>Risk assessment</subject><subject>Risk Factors</subject><subject>Screening</subject><subject>Secretion</subject><subject>Sensitivity</subject><subject>Sensitivity analysis</subject><subject>Strategy</subject><subject>Womens health</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk11rFDEUhgdRrFb_gWhAEL3YNcnkY3Ij1KrtQqFQvy7DmcyZ3ZTZSU0yYv-9WbstXSkoczFD5nnfc_Imp6qeMTpntWZvz8MURxjmF2HEOWVSc83vVY-YqflMcVrfv_W9Vz1O6ZxSWTdKPaz2CtpIRsWjCo6GyYWEZDHmMGCE0SGBPmMkQM7Q4ZjJsU85xEsSenKEKUP2oRQmHzy0mDGR95CwI2EkeYWEU1aT78en5DD64uLhSfWghyHh0-17v_r66eOXw-PZyenR4vDgZOa0YXnmWCN71mBvOpCC9rwVSFWjhRFNz6RSXIDhHSinkHUGHeeUMiYlbxUVrqn3qxdXvhdDSHabTrJMmyIWUppCLK6ILsC5vYh-DfHSBvD2z0KISwsxezegVZqbWpi2VBQCBINWcK1BK-hoyztXvN5tq03tGrtNThGGHdPdP6Nf2WX4aYWhvKaiGLzeGsTwYyqx2rVPDocBRgxT6buhTWlCNfzfqDZKNVIbXdCXf6F3B7GlllD26sc-lBbdxtQeCCm0NEZsvOZ3UOXpcO1duXW9L-s7gjc7gsJk_JWXMKVkF5_P_p89_bbLvrrFrhCGvEphmDb3MO2C4gp0MaQUsb85D0btZmiu07CbobHboSmy57fP8kZ0PSX1b2UGDmw</recordid><startdate>20160610</startdate><enddate>20160610</enddate><creator>Benhalima, Katrien</creator><creator>Jegers, Katleen</creator><creator>Devlieger, Roland</creator><creator>Verhaeghe, Johan</creator><creator>Mathieu, Chantal</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20160610</creationdate><title>Glucose Intolerance after a Recent History of Gestational Diabetes Based on the 2013 WHO Criteria</title><author>Benhalima, Katrien ; Jegers, Katleen ; Devlieger, Roland ; Verhaeghe, Johan ; Mathieu, Chantal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c791t-c185f18ef9da540f2b4e06874948f156624a92da6c6e1d9ec220011552b604c83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Analysis</topic><topic>Beta cells</topic><topic>Biology and Life Sciences</topic><topic>Blood glucose</topic><topic>Blood Glucose - analysis</topic><topic>Body mass</topic><topic>Breast feeding</topic><topic>Breastfeeding &amp; lactation</topic><topic>Chromium</topic><topic>Complications and side effects</topic><topic>Criteria</topic><topic>Demographic aspects</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes, Gestational - epidemiology</topic><topic>Diagnosis</topic><topic>Endocrinology</topic><topic>Fasting</topic><topic>Female</topic><topic>Gestational diabetes</topic><topic>Glucose</topic><topic>Glucose intolerance</topic><topic>Glucose Intolerance - blood</topic><topic>Glucose Intolerance - diagnosis</topic><topic>Glucose Intolerance - epidemiology</topic><topic>Glucose tolerance</topic><topic>Glucose Tolerance Test</topic><topic>Gynecology</topic><topic>Homeostasis</topic><topic>Humans</topic><topic>Insulin</topic><topic>Insulin Resistance</topic><topic>Insulin-Secreting Cells - pathology</topic><topic>Intolerance</topic><topic>Laboratory testing</topic><topic>Medical records</topic><topic>Medicine and Health Sciences</topic><topic>Minority &amp; ethnic groups</topic><topic>Obstetrics</topic><topic>Population</topic><topic>Postpartum</topic><topic>Postpartum Period</topic><topic>Prediabetic State - blood</topic><topic>Prediabetic State - diagnosis</topic><topic>Prediabetic State - epidemiology</topic><topic>Pregnancy</topic><topic>Primary care</topic><topic>Regression analysis</topic><topic>Retrospective Studies</topic><topic>Risk analysis</topic><topic>Risk assessment</topic><topic>Risk Factors</topic><topic>Screening</topic><topic>Secretion</topic><topic>Sensitivity</topic><topic>Sensitivity analysis</topic><topic>Strategy</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Benhalima, Katrien</creatorcontrib><creatorcontrib>Jegers, Katleen</creatorcontrib><creatorcontrib>Devlieger, Roland</creatorcontrib><creatorcontrib>Verhaeghe, Johan</creatorcontrib><creatorcontrib>Mathieu, Chantal</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Benhalima, Katrien</au><au>Jegers, Katleen</au><au>Devlieger, Roland</au><au>Verhaeghe, Johan</au><au>Mathieu, Chantal</au><au>Pietropaolo, Massimo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glucose Intolerance after a Recent History of Gestational Diabetes Based on the 2013 WHO Criteria</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2016-06-10</date><risdate>2016</risdate><volume>11</volume><issue>6</issue><spage>e0157272</spage><epage>e0157272</epage><pages>e0157272-e0157272</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Uncertainty exists on the prevalence of glucose intolerance in women with a recent diagnosis of gestational diabetes (GDM) based on a two-step screening strategy and the 2013 World Health Organization (WHO) criteria. Our aim was to evaluate the uptake of postpartum screening, the prevalence and the risk factors for glucose intolerance in women with a recent history of GDM. Retrospective analysis of the medical records of women with a recent history of GDM diagnosed in a universal two-step screening strategy with the 2013 WHO criteria. All women with a history of GDM are advised to undergo a 75g oral glucose tolerance test (OGTT) around 12 weeks postpartum. Indices of insulin sensitivity (the Matsuda index and the reciprocal of the homeostasis model assessment of insulin resistance, 1/HOMA-IR) and an index of beta-cell function, the Insulin Secretion-Sensitivity Index-2 (ISSI-2) were calculated based on the OGTT postpartum. Multivariable logistic regression was used to adjust for confounders such as age, BMI, ethnicity and breastfeeding. Of the 191 women with GDM, 29.3% (56) did not attend the scheduled postpartum OGTT. These women had a higher BMI (28.6 ±6.8 vs. 26.2 ± 5.6, p = 0.015), were more often from an ethnic minority (EM) background (41.1% vs. 25.2%, p = 0.029) and smoked more often during pregnancy (14.3% vs. 2.2%, p = 0.001) than women who attended the OGTT postpartum. Of all women (135) who received an OGTT postpartum, 42.2% (57) had prediabetes (11.9% impaired fasting glucose, 24.4% impaired glucose tolerance and 5.9% both impaired fasting and impaired glucose tolerance) and 1.5% (2) had overt diabetes. Compared to women with a normal OGTT postpartum, women with glucose intolerance were older (32.5±4.3 vs. 30.8±4.8 years, p = 0.049), were more often obese (34.5% vs. 17.3%, p = 0.023), were more often from an EM background (33.9% vs. 18.4%, p = 0.040), less often breastfed (69.5% vs. 84.2%, p = 0.041) and had more often an abnormal fasting glycaemia at the time of the OGTT in pregnancy (55.6% vs. 37.3%, p = 0.040). In the multivariable logistic regression, an EM background [OR = 2.76 (1.15-6.62), p = 0.023] and the HbA1c level at the time of the OGTT in pregnancy [OR = 4.78 (1.19-19.20), p = 0.028] remained significant predictors for glucose intolerance postpartum. Women with glucose intolerance postpartum had a similar insulin sensitivity [Matsuda index 0.656 (0.386-1.224) vs. 0.778 (0.532-1.067), p = 0.709; 1/HOMA-IR 0.004 (0.002-0.009) vs. (0.004-0.003-0.007), p = 0.384] but a lower beta-cell function compared to women with a normal OGTT postpartum, remaining significant after adjustment for confounders [ISSI-2 1.6 (1.2-2.1) vs. 1.9 (1.7-2.4),p = 0.002]. Glucose intolerance is very frequent in early postpartum in women with GDM based on the 2013 WHO criteria in a two-step screening strategy and these women have an impaired beta-cell function. Nearly one third of women did not attend the scheduled OGTT postpartum and these women have an adverse risk profile. More efforts are needed to engage and stimulate women with GDM to attend the postpartum OGTT.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>27285104</pmid><doi>10.1371/journal.pone.0157272</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2016-06, Vol.11 (6), p.e0157272-e0157272
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1795664559
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS)
subjects Adult
Analysis
Beta cells
Biology and Life Sciences
Blood glucose
Blood Glucose - analysis
Body mass
Breast feeding
Breastfeeding & lactation
Chromium
Complications and side effects
Criteria
Demographic aspects
Diabetes
Diabetes mellitus
Diabetes, Gestational - epidemiology
Diagnosis
Endocrinology
Fasting
Female
Gestational diabetes
Glucose
Glucose intolerance
Glucose Intolerance - blood
Glucose Intolerance - diagnosis
Glucose Intolerance - epidemiology
Glucose tolerance
Glucose Tolerance Test
Gynecology
Homeostasis
Humans
Insulin
Insulin Resistance
Insulin-Secreting Cells - pathology
Intolerance
Laboratory testing
Medical records
Medicine and Health Sciences
Minority & ethnic groups
Obstetrics
Population
Postpartum
Postpartum Period
Prediabetic State - blood
Prediabetic State - diagnosis
Prediabetic State - epidemiology
Pregnancy
Primary care
Regression analysis
Retrospective Studies
Risk analysis
Risk assessment
Risk Factors
Screening
Secretion
Sensitivity
Sensitivity analysis
Strategy
Womens health
title Glucose Intolerance after a Recent History of Gestational Diabetes Based on the 2013 WHO Criteria
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T18%3A01%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glucose%20Intolerance%20after%20a%20Recent%20History%20of%20Gestational%20Diabetes%20Based%20on%20the%202013%20WHO%20Criteria&rft.jtitle=PloS%20one&rft.au=Benhalima,%20Katrien&rft.date=2016-06-10&rft.volume=11&rft.issue=6&rft.spage=e0157272&rft.epage=e0157272&rft.pages=e0157272-e0157272&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0157272&rft_dat=%3Cgale_plos_%3EA454759947%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1795664559&rft_id=info:pmid/27285104&rft_galeid=A454759947&rft_doaj_id=oai_doaj_org_article_6729349b92d44a41ab4277a76ad0b2dc&rfr_iscdi=true